Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Psychiatry. 2021 Jul 14;178(9):829–837. doi: 10.1176/appi.ajp.2021.20121757

Table 1.

Study Population Demographic and Drinking Characteristics

No. (%)
Characteristic Total (n=68) Gabapentin (n=37) Placebo (n=31) p valuea
Age, mean (SD), y 49.3 10.6 49.6 10.4 48.9 10.9 0.78
PTSD (current or past) 18 26.5% 9 24.3% 9 29.0% 0.66
Nicotine use 31 45.6% 17 45.9% 14 45.2% 0.95
Antidepressant use 18 26.5% 9 24.3% 9 29.0% 0.66
Sex (male) 50 73.5% 28 75.7% 22 71.0% 0.66
Married/cohabitating 29 42.6% 19 51.4% 10 32.3% 0.11
Education (≤ 12 y) 8 11.8% 5 13.5% 3 9.7% 0.62
Employed 49 72.1% 26 70.3% 23 74.2% 0.72
Race (white) 65 95.6% 35 94.6% 30 96.8% 0.66
Alcohol use and severity indicators, mean (SD)
 Drinks per dayb 11.0 4.6 10.8 4.3 11.2 5.0 0.77
 Drinks per drinking dayb 13.0 4.8 13.2 4.9 12.8 4.8 0.72
 Days abstinent, %b 14.1% 21.3% 14.9% 22.7% 13.3% 19.8% 0.76
 Heavy drinking days, %b 83.0% 22.3% 82.8% 23.6% 83.2% 21.0% 0.94
 Days abstinent prior to randomization 4.2 2.0 4.2 2.1 4.2 1.9 0.97
 Alcohol Dependence Scalec 18.6 7.5 19.7 7.8 17.4 7.1 0.22
 OCDSd 27.4 9.4 27.9 9.1 26.7 9.9 0.62
 Alcohol Withdrawal Symptom Checkliste 10.5 7.0 10.9 7.4 9.9 6.4 0.53
 DSM-5 alcohol withdrawal items positive 4.5 1.3 4.7 1.1 4.4 1.5 0.36
 CIWA 2.8 1.8 2.8 2.0 2.8 1.6 0.95
Past alcohol:
 Treatments 19 27.9% 13 35.1% 6 19.4% 0.15
 Detoxifications 9 13.2% 7 18.9% 2 6.5% 0.13
Alcohol blood tests (biomarkers)
 %dCDT≥1.7 50 74.6% 26 72.2% 24 77.4% 0.63
 GGT > 36 U/L 52 76.5% 29 78.4% 23 74.2% 0.69

Abbreviations: PTSD, Posttraumatic Stress Disorder; DSM-5, Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition); GGT, y-glutamyltransferase; OCDS, Obsessive Compulsive Drinking Scale; %dCDT, percentage of disialo carbohydrate-deficient transferrin.

a

The χ2 statistic was used for all the categorical variables, and the ANOVA statistic was used for all the continuous variables.

b

Calculated using the 90 days prior to screening.

c

Range, 0–47.

d

Range, 0–56.